Showing results (831-840 of 1,005) with videos related to
Sort By:
Pageof 101
The Journal of Organic Chemistry|April 12, 2017
Conformational Effects through Hydrogen Bonding in a Constrained γ-Peptide Template: From Intraresidue Seven-Membered Rings to a Gel-Forming Sheet StructureHawraà Awada, Claire M Grison, Florence Charnay-Pouget, et al.Cancer Chemotherapy and Pharmacology|April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I studyO van Tellingen, C J Punt, A Awada, et al.Journal of the Science of Food and Agriculture|August 8, 2015
In situ evaluation of the fruit and oil characteristics of the main Lebanese olive germplasmAli Chehade, Ahmad El Bitar, Aline Kadri, et al.Journal of the American Heart Association|November 7, 2012
Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretionScott Turner, Jason Voogt, Michael Davidson, et al.Springerplus|July 22, 2016
Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trialJavier Cortés, Hope S Rugo, Chris Twelves, et al.British Journal of Cancer|December 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumoursDebbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, et al.Biochimica Et Biophysica Acta|March 29, 2006
Measurement of protein turnover rates by heavy water labeling of nonessential amino acidsRobert Busch, Yoo-Kyeong Kim, Richard A Neese, et al.Gynecologic Oncology|June 17, 2023
Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancerNnamdi I Gwacham, Karolina A Kilowski, Fernando O Recio, et al.BMC Cancer|November 25, 2010
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphomaLaetitia Gerlier, Mark Lamotte, Ahmad Awada, et al.European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumoursA Awada, F A L M Eskens, M Piccart, et al.Pageof 101